TRANSDERMALE ABGABESYSTEME

The present invention relates to a transdermal delivery system for administering sufentanil, through the skin, wherein said system provides a dosage form rate control over flux of sufentanil from the system and a net flux from the system through the skin of at least about 1 µg/cm 2 /hour, and furthe...

Full description

Saved in:
Bibliographic Details
Main Authors THEEUWES, FELIX, YUM, SU IL
Format Patent
LanguageGerman
Published 15.04.2012
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a transdermal delivery system for administering sufentanil, through the skin, wherein said system provides a dosage form rate control over flux of sufentanil from the system and a net flux from the system through the skin of at least about 1 µg/cm 2 /hour, and further wherein said system does not contain a permeation enhancer.
Bibliography:Application Number: AT20100003544T